DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."
Nasdaq Stock Snapshot
(844) 557-8483 (domestic)
(825) 312-2381 (international)
Conference ID: 4594493
Listeners should log on to the website or dial in 15 minutes prior to the call.
A telephonic replay of the conference call will be available until November 21, 2019, by dialing (800) 585-8367 (US Toll Free), (416) 621-4642 (International), replay passcode 4594493.